The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

A whistle-blower claims that Takeda Pharmacueticals failed to provide accurate reports about hundreds of congestive heart failures associated with the its diabetes medication Actos. The allegations were made public as part of a lawsuit filed by former Takeda medical reviewer Helen Ge. See the Bloomberg write up here.

Ge claims that the company failed to classify “non-hospitalized or non-fatal” congestive heart failure cases as serious from late 2007 to January of 2010. She alleges that the motivation for concealing these adverse events from regulators was driven by economic decision to improve the safety profile of Actos to increase sales.

Takeda, like all other drug manufacturers, is required to provide an accurate representation of adverse events to regulators, and if these allegations are true, Takeda has attempted to circumvent this requirement in an effort increase profits.

Ge claims that Takeda’s culture is “riddled with systematic fraud and deceit.” She claims that in addition to the hiding congestive heart failure risks, the company also downplayed their own data suggesting a link between Actos and bladder cancer.

The U.S. Justice Department and 24 states have declined to join Ge’s lawsuit, but her attorneys are confident that documents attained during discovery will induce the government to join the case.

The suit was filed under the False Claims Act and seeks to recover damages on behalf of governments that have paid for tens of thousands of false claims through health care programs.

One Comment

  1. Gravatar for Daniel Haszard

    Actos is produced by Takeda Industries and co-marketed by Eli Lilly.

    Eli Lilly Zyprexa can *cause* diabetes.

    I took Zyprexa olanzapine a powerful Lilly schizophrenic drug for 4 years it was prescribed to me off-label for post traumatic stress disorder was ineffective costly and gave me diabetes.

    Eli Lilly's #1 cash cow Zyprexa drug sale $65 billion dollars so far,has a ten times greater risk of causing type 2 diabetes over the non-user of Zyprexa. So,here we have a conflict of interest that this same company Eli Lilly also is a big profiteer of diabetes treatment.

    (Actos works as an insulin *sensitizer*)

    Sooooo,Eli Lilly pushes a drug (Zyprexa) that can cause diabetes.... then turn around sell you the drugs (Actos) to treat the diabetes that in turn can cause cancer!

    What a terrible conflict of interest!

    -- Daniel Haszard

Comments are closed.

Of Interest